Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 8/20 | 0.53 |
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.52 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.52 |
| ▸ | HPGD | P15428 | 1/20 | 0.47 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.47 |
| ▸ | TP53 | P04637 | 3/20 | 0.47 |
| ▸ | HIF1A | Q16665 | 2/20 | 0.47 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.47 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.45 |
| ▸ | THRB | P10828 | 2/20 | 0.37 |
| ▸ | MGLL | Q99685 | 1/20 | 0.33 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19837293 | 0.97 | TSHR (0.53) | TSHRALDH1A1CYP3A4HPGDSMN1; SMN2 | |
| SCHEMBL268151 | 0.97 | TSHR (0.58) | TSHRALDH1A1CYP3A4HPGDSMN1; SMN2 | |
| SCHEMBL5146821 | 0.95 | TSHR (0.59) | TSHRALDH1A1CYP3A4HPGDSMN1; SMN2 | |
| SCHEMBL14244497 | 0.95 | TSHR (0.59) | TSHRALDH1A1CYP3A4HPGDSMN1; SMN2 | |
| SCHEMBL14244554 | 0.95 | TSHR (0.59) | TSHRALDH1A1CYP3A4HPGDSMN1; SMN2 | |
| SCHEMBL14244349 | 0.95 | TSHR (0.59) | TSHRALDH1A1CYP3A4HPGDSMN1; SMN2 | |
| SCHEMBL14244379 | 0.95 | TSHR (0.59) | TSHRALDH1A1CYP3A4HPGDSMN1; SMN2 | |
| SCHEMBL14244602 | 0.95 | TSHR (0.59) | TSHRALDH1A1CYP3A4HPGDSMN1; SMN2 | |
| SCHEMBL672435 | 0.90 | TSHR (0.60) | TSHRALDH1A1CYP3A4HPGDSMN1; SMN2 | |
| SCHEMBL18694991 | 0.90 | TSHR (0.50) | TSHRALDH1A1CYP3A4HPGDSMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 91 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-113817138-A | UV-cured fingerprint-resistant resin with high fluorine content and preparation method and application thereof | 湖南昕逸辰科技有限公司 | 2021-12-21 | — | — | CN | claimed |
| EP-2382315-B1 | NUCLEIC ACID PURIFICATION METHOD | QIAGEN GMBH (DE) | 2015-09-23 | — | — | EP | claimed |
| US-9102935-B2 | Nucleic acid purification method | QIAGEN GMBH (DE) | 2015-08-11 | — | — | US | claimed |
| US-20110319506-A1 | NUCLEIC ACID PURIFICATION METHOD | QIAGEN GMBH | 2011-12-29 | — | — | US | claimed |
| US-20080107909-A1 | USE OF ANTIADHESIVE PACKAGING MATERIALS FOR PACKAGING CHEMICALS AND FOODSTUFFS | BASF AKTIENGESELLSCHAFT (DE) | 2008-05-08 | — | — | US | claimed |
| US-7122599-B2 | Coating compositions and polymeric moulding compounds having anti-adhesion and dirt repellency properties | BYK-CHEMIE GMBH (DE) | 2006-10-17 | — | — | US | claimed |
| EP-1474491-B1 | USE OF ANTI-ADHESIVE PACKAGING MATERIALS FOR PACKAGING CHEMICALS AND FOOD | BASF AG (DE) | 2006-03-08 | — | — | EP | claimed |
| US-20050079301-A1 | Use of antiadhesive packaging materials for packaging chemicals and foodstuffs | BASF AKTIENGESELLSCHAFT (DE) | 2005-04-14 | — | — | US | claimed |
| EP-1193303-B1 | Coating composition and polymeric molding materials having anti-adhesive, soil-release properties | BYK CHEMIE GMBH (DE) | 2005-03-09 | — | — | EP | claimed |
| US-20020103288-A1 | Coating compostions and polymeric moulding compounds having anti-adhesion and dirt repellency properties | BYK-CHEMIE GMBH (DE) | 2002-08-01 | — | — | US | claimed |
| WO-2026104223-A1 | PROCESS FOR UTILIZING REACTION RESIDUES FROM MANUFACTURE OF AQUEOUS POLYMER DISPERSIONS | BASF SE (DE) | 2026-05-21 | — | — | WO | disclosed |
| EP-4727905-A1 | COMPOSITIONS FOR CONSTRUCTION PURPOSES | BASF SE (DE) | 2026-04-22 | — | — | EP | disclosed |
| US-20250355282-A1 | LAYERED BODY, OPTICAL ARTICLE, LENS, AND SPECTACLES | TOKUYAMA CORPORATION (JP) | 2025-11-20 | — | — | US | disclosed |
| EP-4587247-A1 | METHOD FOR PRODUCING AQUEOUS POLYMER DISPERSIONS FROM ORGANIC WASTE MATERIALS | BASF SE (DE) | 2025-07-23 | — | — | EP | disclosed |
| EP-4560367-A1 | LAYERED BODY, OPTICAL ARTICLE, LENS, AND SPECTACLES | TOKUYAMA CORPORATION (JP) | 2025-05-28 | — | — | EP | disclosed |
| EP-1494072-A2 | Radiation sensitive refractive index changing composition, pattern forming method and optical material | JSR Corporation (JP) | 2005-01-05 | — | — | EP | disclosed |
| US-20040265737-A1 | Radiation sensitive refractive index changing composition, pattern forming method and optical material | JSR CORPORATION (JP) | 2004-12-30 | — | — | US | disclosed |
| US-20020103288-A1 | Coating compostions and polymeric moulding compounds having anti-adhesion and dirt repellency properties | BYK-CHEMIE GMBH (DE) | 2002-08-01 | — | — | US | disclosed |
| US-4664936-A | Aromatic polyamide fiber-based composite prepreg | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 1987-05-12 | — | — | US | disclosed |
| EP-0191680-A1 | An aromatic polyamide fiber-based composite prepreg | Shin-Etsu Chemical Co., Ltd. (JP) | 1986-08-20 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110319506-A1 | NUCLEIC ACID PURIFICATION METHOD | POLL, SAMHD1, POLB | TSHR 2755/4885ALDH1A1 3170/4885CYP3A4 4418/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.